Filing Details

Accession Number:
0001209191-16-093451
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-25 19:20:02
Reporting Period:
2016-01-22
Filing Date:
2016-01-25
Accepted Time:
2016-01-25 19:20:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1290149 Pronai Therapeutics Inc DNAI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647652 Wendy Chapman C/O Pronai Therapeutics, Inc.,
2150 885 West Georgia St.
Vancouver A1 V6C 3E8
Svp Clinical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-22 5,000 $0.97 5,000 No 4 M Direct
Common Stock Disposition 2016-01-22 5,000 $9.39 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-01-22 5,000 $0.00 5,000 $0.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
82,248 2024-09-22 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.15 to $9.66 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The option vests as to 25% of the total shares on September 22, 2015, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on September 22, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. The option is immediately exercisable.